Categories
Essays
Links
Category Archives: Industry
Interview with James Carroll by Dr Hisham Abdalla
Dr Hisham Abdalla from laser lifeCARE institute interviews James Carroll CEO, Founder and Inventor of Thor Photomedicine and the NovoTHOR light-pod.
James Carroll shares visions, science, evolution and the future of PhotoBiomodulation and Light/laser therapies, as well as James’s recent achievements at the US Congress and The United Nations.
View current photobiomodulation therapy training dates in your location.
Posted in Industry, Interviews, James in Action, Video of the Week
on Interview with James Carroll by Dr Hisham Abdalla
Podcast interview of James Carroll by Gut Check Project
“Photobiomodulation … If you’ve never heard of this well researched and incredible technology to decrease inflammation and shorten healing time, watch our Podcast Video! PBM has successfully helped thousands of people in over 70 countries with chronic pain, macular degeneration, shingles pain, recovery from athletic injury, CTE, PTSD and more. Check out ThorLaser.com to connect with James, his research, and how THOR PBM can improve your life.”
Gut Check Project
Kenneth Brown, MD
Board Certified Gastroenterologist
View current photobiomodulation therapy training dates in your location.
Posted in Industry, Interviews, James in Action, THE FUTURE OF PBM/LLLT, Video of the Week
on Podcast interview of James Carroll by Gut Check Project
James Carroll’s Photobiomodulation and NovoTHOR interview
Laser Therapy Sydney interviews James Carroll CEO and Founder of Thor Photomedicine and the NovoTHOR light-pod.
James Carroll sheds light on what Photobiomodulation is and what conditions it can treat; who is using it and how Thor products are different; oral mucositis and the opioid crisis; and the future of PBM in Australia.
View current photobiomodulation therapy training dates in your location.
Posted in Industry, Interviews, James in Action, THE FUTURE OF PBM/LLLT, Video of the Week
on James Carroll’s Photobiomodulation and NovoTHOR interview
Congressional Briefing Highlight Video
U.S. CONGRESSIONAL BRIEFING. Ending Opioid Use – Washington DC
James Carroll presented evidence to Congress on the effectiveness of PBM for treating pain and where it can be used in place of opioids. Prof. Praveen Arany explained how and why it works, and Annette Quinn RN gave her first hand experience in treating over 854 patients with Oral Mucositis.
Learn more at CongressPBM.com
Watch James Carroll’s Congress speech on ending opioid use with Photobiomodulation
Read James Carroll’s Speech to Congress on citizenoversight.blogspot.com
View current photobiomodulation therapy training dates in your location.
Posted in Industry, James in Action, THE FUTURE OF PBM/LLLT, Video of the Week
on Congressional Briefing Highlight Video
LumiThera Receives Notice of Award for $2.5 Million National Eye Institute Grant to Support U.S. Multi-Center Clinical Trial for Treating Dry Age-Related Macular Degeneration
LumiThera Inc., a commercial stage medical device company creating a photobiomodulation (PBM) treatment for ocular disorders and disease, today announced it is a recipient of a small business innovative research (SBIR) phase II grant from the National Institute of Health (NIH) and the division of the National Eye Institute (NEI).
The phase II grant supports a prospective, randomized, multi-center human clinical trial in U.S. subjects diagnosed with dry age-related macular degeneration (dry AMD.) The LIGHTSITE III trial, which is subject to FDA Investigational Device Exemption (IDE) approval, will test vision and examine disease pathology in the eye following PBM treatments using the Company’s Valeda™ Light Delivery System. Subjects will be followed for up to two years. In 2018, LumiThera obtained a CE mark to commercialize the Valeda™ Light Delivery … Continue reading
Posted in Industry
on LumiThera Receives Notice of Award for $2.5 Million National Eye Institute Grant to Support U.S. Multi-Center Clinical Trial for Treating Dry Age-Related Macular Degeneration
Ending Opioids by Photobiomodulation
James Carroll, CEO and founder of THOR Photomedicine – Speech to Congress.
We are all aware there is an opioid crisis.
- A hundred million adults in the United States are affected by chronic pain and $600 billion a year is spent on in direct health care costs and lost productivity because of pain.
- 49,000 people died from opioids in 2017.
- 19,000 of which were from prescribed opioids for pain relief.
We believe that Photobiomodulation therapy can help reduce the prescribing of opioid medication for pain relief and we wish to draw attention to the Congress and health care policymakers, NIH and CMS, about this potentially valuable tool.
Read the full Speech to Congress on citizenoversight.blogspot.com
Posted in Industry, James in Action, THE FUTURE OF PBM/LLLT
on Ending Opioids by Photobiomodulation
James Carroll’s Congress speech on ending opioid use with Photobiomodulation
A hundred million adults in the United States are affected by chronic pain and $600 billion a year is spent on health care, direct health care costs and lost productivity because of pain.
49,000 people died from opioids in 2017, 19,000 of which were from prescribed opioids for pain relief.
We believe that Photobiomodulation therapy can help reduce the prescribing of opioid medication for pain relief and we wish to draw attention to the Congress and health care policymakers, NIH and CMS, about this potentially valuable tool.
Learn more at CongressPBM.com
Watch the Congressional Briefing Highlight Video
Read James Carroll’s Speech to Congress on citizenoversight.blogspot.com
Posted in Industry, James in Action, THE FUTURE OF PBM/LLLT, Video of the Week
on James Carroll’s Congress speech on ending opioid use with Photobiomodulation